• Home
  • EnBridge PharmTech (Wuxi) Co., Ltd.

EnBridge PharmTech (Wuxi) Co., Ltd.

About EnBridge PharmTech (Wuxi) Co., Ltd.

Enbridge PharmTech Co., Ltd. was established in 2013. Our service includes CRO&CDMO on advanced intermediates of API in our own lab&plant. We also help our abroad clients to source chemical materials in China, such as food additives, vitamins, cosmetic ingredients. Our strong products include advanced intermediates of API,  Phytic Acid, Sodium Phytate, Benzoic Acid, L-Arginine, L...

Read more Show less
Certifications
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2016
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Contact info
  • +86-13812269233
  • Website
  • Rm601, Bldg5,, Huaqing Creative Park,, Huishan Economic Development Zone,, 214174, Wuxi City, Jiangsu Province, China
Show contact info Hide contact info

Products from EnBridge PharmTech (Wuxi) Co., Ltd. (3)

  • ((2r,3r,4r)-3-(Benzoyloxy)-4-

    Product ((2r,3r,4r)-3-(Benzoyloxy)-4-

    EnBridge PharmTech (Wuxi) Co., Ltd. offers a wide range of products which includes ((2r,3r,4r)-3-(benzoyloxy)-4-fluoro-4-methyl. It belongs to fine chemicals category. Contact us for more information.
  • ((2r,3r,4r)-3-(Benzoyloxy)-4-Fluoro-

    Product ((2r,3r,4r)-3-(Benzoyloxy)-4-Fluoro-

    EnBridge PharmTech (Wuxi) Co., Ltd. offers a wide range of products which includes ((2r,3r,4r)-3-(benzoyloxy)-4-fluoro-4-methyl-5. It belongs to active pharmaceutical ingredient. Contact us for more information.
  • (1r,2r)-(-)-1,2-Cyclohexanedi

    Product (1r,2r)-(-)-1,2-Cyclohexanedi

    EnBridge PharmTech (Wuxi) Co., Ltd. offers a wide range of products which includes (1r,2r)-(-)-1,2-cyclohexanedi. It belongs to active pharmaceutical ingredient. Contact us for more information.